Mood disorders in children and adolescents: Psychopharmacological treatment

Biological Psychiatry

Volumn 49, Issue 12, 2001, Pages 1082-1090

  Emslie, Graham J ^a   Mayes, Taryn L ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Adolescents; Antidepressants; Bipolar disorder; Children; Depression; Mood stabilizers

Indexed keywords

CARBAMAZEPINE; FLUOXETINE; GABAPENTIN; IMIPRAMINE; LITHIUM; NEUROLEPTIC AGENT; OLANZAPINE; PAROXETINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROATE SEMISODIUM; VENLAFAXINE;

ADOLESCENCE; AFFECTIVE NEUROSIS; ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR THERAPY; CHILD PSYCHIATRY; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; DEPRESSION; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; HUMAN; MANIC DEPRESSIVE PSYCHOSIS; MORBIDITY; MORTALITY; POLYPHARMACY; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; RECURRENT DISEASE; RELAPSE; SEDATION; SIDE EFFECT; WEIGHT GAIN;

EID: 0035875567     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(01)01149-0     Document Type: Review

References (68)

1. Affective disorders in referred children and younger siblings of manic-depressives. Mode of onset and prospective course
2. The depressive spectrum: Diagnostic classification and course
3. Childhood-onset depressive disorders. A follow-up study of rates of rehospitalization and out-of-home placement among child psychiatry inpatients
4. Correlates of the medical lethality of suicide attempts in children and adolescents
5. Difficulties in diagnosing manic disorders among children and adolescents
6. Behavioral efficacy of haloperidol and lithium carbonate. A comparison in hospitalized aggressive children with conduct disorder
7. Lithium in hospitalized children at 4 and 8 weeks: Mood, behavior and cognitive effects
8. Mood stabilizer augmentation with olanzapine in acutely manic children
9. Lithium-induced behavior changes in children with symptoms suggesting manic-depressive illness
10. Naturalistic experience with the use of divalproex sodium on an inpatient unit for adolescent psychiatric patients
11. Divalproex treatment for youth with explosive temper and mood lability: A double-blind, placebo-controlled crossover design
12. Long-term outcome of depressed children: A follow-up study
13. Fluoxetine for acute treatment of depression in children and adolescents: A placebo-controlled, randomized clinical trial
14. Fluoxetine for maintenance of recovery from depression in children and adolescents: A placebo-controlled, randomized clinical trial
15. Updates in the pharmacologic treatment of childhood depression
16. Double-blind, randomized placebo-controlled trial of fluoxetine in depressed children and adolescents
17. Recurrence of major depressive disorder in hospitalized children and adolescents
18. Fluoxetine in child and adolescent depression: Acute and maintenance treatment
19. The outcome of adolescent depression in the Ontario child health study follow-up
20. Epidemiology of childhood depressive disorders: A critical review
21. Olanzapine in the treatment of bipolar disorder in juveniles
22. Risperidone treatment for juvenile bipolar disorder: A retrospective chart review
23. The mania rating scale: Can it be used in children? A preliminary report
24. Recurrent depression in adolescents: A follow-up study
25. Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency
26. Child and adolescent bipolar disorder: A review of the past 10 years
27. Complex and rapid-cycling in bipolar children and adolescents: A preliminary study
28. Prepubertal and young adolescent bipolarity versus ADHD: Assessment and validity using the WASH-U-KSADS, CBCL and TRF
29. Six-month stability and outcome of a prepubertal and early adolescent bipolar disorder phenotype
30. Social influences on the course of anxious and depressive disorders in school-age children
31. Efficacy of tricyclic drugs in treating child and adolescent depression: A meta-analysis
32. Lithium response in acute adolescent mania
33. Course of major depression in non-referred adolescents: A retrospective study
34. Relapse in major depressive disorder: Analysis with the life table
35. Sex and depression in the national comorbidity survey: II. Cohort effects
36. Presentation and course of major depressive disorder during childhood and later years of the life span
37. Depressive disorders in childhood: I. A longitudinal prospective study of characteristics and recovery
38. Depressive disorders in childhood: II. A longitudinal study of the risk for a subsequent major depression
39. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder
40. Bipolar disorders in a community sample of older adolescents: Prevelence, phenomenology, comorbidity, and course
41. Natural course of adolescent major depressive disorder in a community sample: Predictors of recurrence in young adults
42. Depression in young people: Initial presentation and clinical course
43. A longitudinal study of depression in nine-year-old children
44. Lithium in children of lithium-responding parents
45. Divalproex sodium treatment in late adolescent and young adult acute mania
46. Suicidal children grow up: Demographic and clinical risk factors for adolescent suicide attempts
47. Dysphoric mania: Clinical and biological correlates
48. Childhood depression
49. Unipolar depression in adolescents: Clinical outcome in adulthood
50. Gabapentin in bipolar disorder
51. Risperidone for young children with mood disorders and aggressive behavior
52. The NIMH diagnostic interview schedule for children version 2.3 (DISC-2.3): Description, acceptability, prevalence rates, and performance in the MECA study. Methods for the epidemiology of child and adolescent mental disorders study
53. Adolescent depression: A placebo-controlled fluoxetine study and follow up
54. Olanzapine in the treatment of adolescent acute mania: A report of seven cases
55. Early childhood attention deficit hyperactivity disorder predicts poorer response to acute lithium therapy in adolescent mania
56. The course of major depressive disorder in adolescents: I. Recovery and risk of manic switching in a follow-up of psychotic and nonpsychotic subtypes
57. A family study of bipolar I disorder in adolescence. Early onset of symptoms linked to increased familial loading and lithium resistance
58. Relapse following discontinuation of lithium maintenance therapy in adolescents with bipolar I illness: A naturalistic study
59. Recovery and relapse in adolescents with bipolar affecitve illness: A five-year naturalistic, prospective follow-up
60. Safety of paroxetine and imipramine in the treatment of adolescent depression
61. Safety and efficacy of divalproex in childhood bipolar disorder
62. Open trial of fluoxetine in children and adolescents with dysthymic disorder or double depression
63. Lithium dosage guide for prepubertal children: A preliminary report
64. Trends in the prescribing of psychotropic medications in preschoolers